Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $13.64B | $12.95B | +5.32% |
Cost of Revenue | $3.1B | $2.84B | +8.90% |
Operating Income | $-1.68B | $3.37B | -149.79% |
Net Income | $-2.56B | $2.06B | -224.38% |
EPS (Basic) | $-2.05 | $1.65 | -224.24% |
EPS (Diluted) | $-2.05 | $1.63 | -225.77% |
SG&A Expense | $2.75B | $3.17B | -13.13% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $53.58B | $62.34B | -14.05% |
Current Assets | $12.32B | $14.29B | -13.79% |
Current Liabilities | $10.78B | $13.96B | -22.79% |
Stockholders' Equity | $18.28B | $21.16B | -13.60% |
Long-Term Debt | $23.35B | $25.25B | -7.51% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.54B | $4.08B | -13.18% |
Investing Cash Flow | $-2.51B | $-1.31B | -92.06% |
Financing Cash Flow | $-4.31B | $-2.51B | -72.08% |
Dividends Paid | $1.96B | $1.91B | +2.56% |
Share Buybacks | $500M | $550M | -9.09% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -12.3% | 26.0% | -38.32% |
Net Margin | -18.7% | — | — |
ROE | -14.0% | — | — |
ROA | -4.8% | — | — |
Current Ratio | $1.142 | — | — |
Other companies in Biotechnology